Septic shock
Septic shock | |
---|---|
Infectious disease |
Septic shock is a potentially fatal
The primary infection is most commonly caused by
Frequently, people with septic shock are cared for in
Causes
Septic shock is a result of a systemic response to infection or multiple infectious causes. The precipitating infections that may lead to septic shock if severe enough include but are not limited to
According to the earlier definitions of sepsis updated in 2001,[6] sepsis is a constellation of symptoms secondary to an infection that manifests as disruptions in heart rate, respiratory rate, temperature, and white blood cell count. If sepsis worsens to the point of end-organ dysfunction (kidney failure, liver dysfunction, altered mental status, or heart damage), then the condition is called severe sepsis. Once severe sepsis worsens to the point where blood pressure can no longer be maintained with intravenous fluids alone, then the criterion has been met for septic shock.[citation needed]
Pathophysiology
The pathophysiology of septic shock is not entirely understood, but it is known that a key role in the development of severe sepsis is played by an immune and coagulation response to an infection. Both pro-inflammatory and anti-inflammatory responses play a role in septic shock.[7] Septic shock involves a widespread inflammatory response that produces a hypermetabolic effect. This is manifested by increased cellular respiration, protein catabolism, and metabolic acidosis with a compensatory respiratory alkalosis.[8]
Most cases of septic shock are caused by
Gram-positive
In gram-positive bacteria, these are
Gram-negative
In gram-negative sepsis, free LPS attaches to a circulating
In response to inflammation, a compensatory reaction of production of anti-inflammatory substances such as IL-4, IL-10 antagonists, IL-1 receptor, and cortisol occurs. This is called compensatory anti-inflammatory response syndrome (CARS).[10] Both the inflammatory and anti-inflammatory reactions are responsible for the course of sepsis and are described as MARS (Mixed Antagonist Response Syndrome). The aim of these processes is to keep inflammation at an appropriate level. CARS often leads to suppression of the immune system, which leaves patients vulnerable to secondary infection.[7] It was once thought that SIRS or CARS could predominate in a septic individual, and it was proposed that CARS follows SIRS in a two-wave process. It is now believed that the systemic inflammatory response and the compensatory anti-inflammatory response occur simultaneously.[10]
At high levels of LPS, the syndrome of septic shock supervenes; the same cytokine and secondary mediators, now at high levels, result in systemic vasodilation (hypotension), diminished myocardial contractility, widespread endothelial injury, activation causing systemic leukocyte adhesion and diffuse alveolar capillary damage in the lung, and activation of the coagulation system culminating in disseminated intravascular coagulation (DIC).
The hypoperfusion from the combined effects of widespread vasodilation, myocardial pump failure, and DIC causes multiorgan system failure that affects the liver, kidneys, and central nervous system, among other organ systems. Recently, severe damage to liver ultrastructure has been noticed from treatment with cell-free toxins of Salmonella.[11] Unless the underlying infection (and LPS overload) is rapidly brought under control, the patient usually dies.[citation needed]
The ability of
Diagnosis
According to current guidelines, requirements for diagnosis with sepsis are "the presence (probable or documented) of infection together with systemic manifestations of infection".[8] These manifestations may include:
- PaCOless than 32 mm Hg, which signifies hyperventilation
2 - White blood cell count either significantly low (< 4000 cells/mm3), or elevated (> 12000 cells/mm3)
- Tachycardia (rapid heart rate), which in sepsis is defined as a rate greater than 90 beats per minute
- Altered body temperature: Fever> 38.0 °C (100.4 °F) or hypothermia < 36.0 °C (96.8 °F)
Documented evidence of infection may include positive blood culture, signs of pneumonia on chest x-ray, or other radiologic or laboratory evidence of infection. Signs of end-organ dysfunction are present in septic shock, including kidney failure, liver dysfunction, changes in mental status, or elevated serum lactate.
Septic shock is diagnosed if there is low blood pressure (BP) that does not respond to treatment. This means that intravenous fluid administration alone is not enough to maintain a patient's BP. Diagnosis of septic shock is made when
Definition
Septic shock is a subclass of
Septic shock may be defined as sepsis-induced
Septic shock may be regarded as a stage of SIRS (Systemic Inflammatory Response Syndrome), in which sepsis, severe sepsis and multiple organ dysfunction syndrome (MODS) represent different stages of a pathophysiological process. If an organism cannot cope with an infection, it may lead to a systemic response - sepsis, which may further progress to severe sepsis, septic shock, organ failure, and eventually, result in death.[citation needed]
Treatment
Treatment primarily consists of the following:
- Giving intravenous fluids[13]
- Early antibiotic administration [13]
- Early goal directed therapy[13]
- Rapid source identification and control
- Support of major organ dysfunction
Fluids
Because lowered blood pressure in septic shock contributes to poor perfusion,
Antibiotics
Treatment guidelines call for the administration of
Vasopressors
Among the choices for
Methylene blue
Methylene blue has been found to be useful for this condition.[17][18][19][20] Although use of methylene blue has mostly been in adults it has also been shown to work in children.[21][22] Its mechanism of action is thought to be via the inhibition of the nitric oxide-cyclic guanosine monophosphate pathway.[23] This pathway is excessively activated in septic shock. Methylene blue has been found to work in cases resistant to the usual agents.[24] This effect was first reported in the early 1990s.[25][26]
Other
While there is tentative evidence for β-Blocker therapy to help control heart rate, evidence is not significant enough for its routine use.[27][28] There is tentative evidence that steroids may be useful in improving outcomes.[29]
Tentative evidence exists that
Epidemiology
Sepsis has a worldwide incidence of more than 20 million cases a year, with mortality due to septic shock reaching up to 50 percent even in industrialized countries.[33]
According to the U.S.
Tertiary care centers (such as
The process of infection by bacteria or fungi may result in systemic signs and symptoms that are variously described. Approximately 70% of septic shock cases were once traceable to
35% of septic shock cases derive from
The mortality rate from sepsis, especially if it is not treated rapidly with the needed medications in a hospital, is approximately 40% in adults and 25% in children. It is significantly greater when sepsis is left untreated for more than seven days.[34]
References
- PMID 26903338.
- McGraw-Hill. pp. 1003–14. Retrieved December 11, 2012 – via AccessMedicine.
- ^ ISBN 9781416029731.
- PMID 16847244.
- ^ PMID 22977764.
- S2CID 11214199.
- ^ PMID 23984731.
- ^ S2CID 34855187.
- ^ PMID 22734959.
- ^ S2CID 11156883.
- ^ YashRoy R (June 1994). "Liver damage by intra-ileal treatment with Salmonella 3,10:r:- extract as studied by light and electron microscopy". Indian Journal of Animal Sciences. 64 (6): 597–99 – via ResearchGate.(animal study).
- PMID 26635809.
- ^ S2CID 20763016.
- S2CID 249711011.
- PMID 21436167.
- ^ Commissioner Oo. "Press Announcements - FDA approves drug to treat dangerously low blood pressure". www.fda.gov. Retrieved 2017-12-22.
- ^ Jang DH, Nelson LS, Hoffman RS (2013) Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol 9(3):242-249
- ^ Baldo CF, Silva LM, Arcencio L, Albuquerque AAS, Celotto AC, Basile-Filho A, Evora PRB (2018) Why Methylene Blue have to be always present in the tocking of emergency antidotes. Curr Drug Targets 19(13):1550-1559
- ^ McCartney SL, Duce L, Ghadimi K (2018) Intraoperative vasoplegia: methylene blue to the rescue! Curr Opin Anaesthesiol. 31(1):43-49
- ^ Booth AT, Melmer PD, Tribble B, Mehaffey JH, Tribble C (2017) Methylene blue for vasoplegic syndrome. Heart Surg Forum 20(5):E234-E238
- ^ Rutledge C, Brown B, Benner K, Prabhakaran P, Hayes L (2015) A novel use of methylene blue in the pediatric ICU. Pediatrics 136(4):e1030-4
- ^ Volpon LC, Evora PRB, Teixeira GD, Godinho M, Scarpelini S, Carmona F, Carlotti APCP (2018) Methylene blue for refractory shock in polytraumatized patient: A case report. J Emerg Med 55(4):553-558
- ^ Da Silva PS, Furtado P (2018) Methylene blue to treat refractory latex-induced anaphylactic shock: a case report. A A Pract 10(3):57-60
- ^ Lo JC, Darracq MA, Clark RF (2014) A review of methylene blue treatment for cardiovascular collapse. J Emerg Med 46(5):670-679
- ^ Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempé JD (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18(5):309-11
- ^ Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, Kahn RJ, Vincent JL (1995) Methylene blue administration in septic shock: a clinical trial. Crit Care Med 23(2):259-264
- PMID 26702201.
- S2CID 22393745.
- PMID 31808551.
- S2CID 28404720.
- PMID 25043934.
- PMID 23235609.
- ^ "Researchers make blood poisoning breakthrough". Phys.org. June 4, 2010.
- ISBN 9780323049900.[page needed]